echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Instruction of 1,1-Dimethylethyl 4-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-piperazinecarboxylate

    The Instruction of 1,1-Dimethylethyl 4-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-piperazinecarboxylate

    • Last Update: 2023-05-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The manufacturing of pharmaceuticals is a complex and highly regulated process, requiring the coordination of multiple departments and the use of specialized equipment and facilities.
    One crucial step in this process is the synthesis of active pharmaceutical ingredients (APIs), which are the molecules that provide the therapeutic effects of a drug.
    The synthesis of APIs requires the use of a variety of chemical reactions, such as alkylations, aromatizations, and reductions, to create the desired molecule.


    One example of an API synthesized through chemical reactions is 1,1-dimethylethyl 4-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-piperazinecarboxylate.
    This molecule is used in the treatment of cancer and is often referred to by its trade name, Gemcitabine.


    The synthesis of Gemcitabine begins with the creation of a starting material, which is a molecule known as 1,1-dimethylethylamine.
    This molecule is synthesized through a series of steps involving the reaction of dimethylamine and methyl iodide, followed by the reduction of the resulting nitrile to an amine using hydrogen gas.


    Next, the 1,1-dimethylethylamine is reacted with 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl acetate, a molecule that contains a protecting group for the sensitive amine group.
    This reaction is carried out in the presence of a base, such as sodium hydroxide, to catalyze the reaction and remove any impurities.


    After the reaction is complete, the protecting group is removed using hydrochloric acid, and the resulting molecule is then hydrolyzed using sodium hydroxide to generate the desired carboxylate.
    Finally, the resulting carboxylate is purified through a series of chromatography steps to remove any impurities and to yield the pure form of Gemcitabine.


    Throughout the synthesis of Gemcitabine, it is important to maintain a high level of purity and quality to ensure the efficacy and safety of the final product.
    This requires the use of specialized equipment and facilities, such as clean rooms and glove boxes, to minimize the introduction of impurities and to control the reaction conditions.
    Additionally, the synthesis of Gemcitabine requires a high level of expertise and experience, as the reaction conditions and purification steps can be complex and sensitive to optimization.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.